PepGen Inc. logo

PepGen Inc.

NASDAQ:PEPG

Overview | Financials
Company Name PepGen Inc.
Symbol PEPG
Currency USD
Price 8.83
Market Cap 287,767,077
Dividend Yield 0%
52-week-range 3.72 - 19.298
Industry Biotechnology
Sector Healthcare
CEO Dr. James G. McArthur Ph.D.
Website https://www.pepgen.com

An error occurred while fetching data.

About PepGen Inc.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also

Related Stocks

Alpha Teknova, Inc. logo

Alpha Teknova, Inc.

TKNO

4.59 USD

Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

STRO

4.12 USD

Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc.

NVCT

6.18 USD

Altimmune, Inc. logo

Altimmune, Inc.

ALT

6.2 USD

VistaGen Therapeutics, Inc. logo

VistaGen Therapeutics, Inc.

VTGN

3.25 USD

Singular Genomics Systems, Inc. logo

Singular Genomics Systems, Inc.

OMIC

5.892 USD

Prelude Therapeutics Incorporated logo

Prelude Therapeutics Incorporated

PRLD

4.85 USD

Kamada Ltd. logo

Kamada Ltd.

KMDA

4.23 USD

Financials

Numbers are in millions USD

Numbers are in millions USD